4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-059032
Director sold 20,141 shares at $9.00 ($181,269)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Dar Zavain · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-14 | Sale : show line 1 in the form 10b5-1 | −20,141 | $9.00 | $181,269 | 53,823 | D |
| Open-market sales · 20,141 sh · avg $9.00 · $181,269 | ||||||
Loading xslF345X05/doc4.xml…